Ankur Drugs & Pharma Ltd.
| BSE: 531683 | Sector: Health care |
| NSE: ANKURDRUGS | ISIN Code: INE238D01012 |
| BSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd |
| NSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd |
Ankur Drugs & Pharma Ltd. (ANKURDRUGS) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 827.95 | -0.96 | 966.90 | 664.10 | 198650.04 |
| Divi's Lab. | 3613.95 | -1.62 | 5425.00 | 3365.10 | 95932.30 |
| Cipla | 944.70 | 1.34 | 1083.15 | 850.00 | 76227.85 |
| Dr Reddy's Labs | 4374.65 | 1.33 | 5613.65 | 3655.00 | 72811.68 |
| Apollo Hospitals | 3838.70 | 1.20 | 5930.70 | 3365.90 | 55192.83 |
| Torrent Pharma. | 2882.15 | 0.75 | 3304.45 | 2485.00 | 48771.74 |
| Gland Pharma | 2647.65 | -0.41 | 4350.00 | 2498.00 | 43606.79 |
| Piramal Enterp. | 1687.70 | 1.36 | 3013.00 | 1561.00 | 40276.96 |
| Abbott India | 18126.10 | 0.75 | 23902.30 | 15525.00 | 38517.96 |
| Biocon | 316.20 | -1.16 | 414.30 | 309.30 | 37962.97 |
| Zydus Lifesci. | 357.75 | 1.09 | 655.00 | 319.40 | 36622.87 |
| Max Healthcare | 370.70 | -0.95 | 472.60 | 251.00 | 35944.18 |
| Alkem Lab | 2990.30 | -1.39 | 4067.70 | 2835.00 | 35749.04 |
| Aurobindo Pharma | 521.30 | 0.00 | 1012.90 | 503.40 | 30542.97 |
| Lupin | 633.55 | 0.58 | 1193.00 | 583.05 | 28798.02 |
| Glaxosmi. Pharma | 1498.55 | -0.04 | 1917.00 | 1433.05 | 25386.94 |
| Laurus Labs | 468.70 | 0.35 | 723.55 | 433.20 | 25185.59 |
| Ipca Labs. | 902.20 | -1.06 | 1383.55 | 831.40 | 22888.81 |
| Syngene Intl. | 567.80 | -0.17 | 699.95 | 508.10 | 22793.19 |
| Pfizer | 4098.30 | -0.16 | 6164.80 | 4068.85 | 18749.72 |
Quick Links for Ankur Drugs & Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
